Neuronal and axonal loss are selectively linked to fibrillar amyloid-β within plaques of the aged primate cerebral cortex

American Journal of Pathology

Volumn 177, Issue 1, 2010, Pages 325-333

  Shah, Palak ^a   Lal, Neeta ^a   Leung, Elaine ^a   Traul, David E ^a   Gonzalo Ruiz, Alicia ^b   Geula, Changiz ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; FIBRILLAR AMYLOID BETA; TAU PROTEIN; UNCLASSIFIED DRUG;

AGED; AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROGLIA; NERVE CELL DEGENERATION; NERVE FIBER DEGENERATION; NEURITE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RHESUS MONKEY; SENILE PLAQUE; TOXICITY;

EID: 77954602193     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090937     Document Type: Article

References (61)

1. Selkoe DJ: Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann NY Acad Sci 2000, 924:17-25
2. Lorenzo A, Yankner BA: B-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc Natl Acad Sci U S A: 1994, 91:12243-12247
3. Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW: In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 1991, 563:311-314
4. Walsh DM, Tseng BP, Rydel RE, Podlisny MB, Selkoe DJ: The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochem 2000, 39:18031-18039
5. Hartley DM, Walsh DM, Ye CP, Diehl T, Vasquez S, Vassilev PM, Teplow DB, Selkoe DJ: Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 1999, 19:8876-8884
6. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG: Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003, 300:486-489 (Pubitemid 36444329)
7. Mann DMA, Brown AMT, Prinja D, Jones D, Davies CA: A morphological analysis of senile plaques in the brains of non-demented persons of different ages using silver, immunocytochemical and lectin histochemical staining techniques. Neuropathol Appl Neurobiol 1990, 16:17-25 (Pubitemid 20141682)
8. Wisniewski HM, Bancher C, Barcikowska M, Wen GY, Currie J: Spectrum of morphological appearance of amyloid deposits in Alzheimer's disease. Acta Neuropathol 1989, 78:337-347 (Pubitemid 19200583)
9. Terry RD, Wisniewski HM. Ultrastructure of senile dementia and of experimental analogues. In: Gaitz CM, editor. Aging and the Brain. New York: Plenum Press; 1972, 89-116
10. Sheng JG, Mrak RE, Griffin WS: Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alpha+ microglia and S100beta+ astrocytes with neurofibrillary tangle stages. J Neuropathol Exp Neurol 1997, 56:285-290
11. Fukumoto H, Asami-Odaka A, Suzuki N, Iwatsubo T: Association of A beta 40-positive senile plaques with microglial cells in the brains of patients with Alzheimer's disease and in non-demented aged individuals. Neurodegen 1996, 5:13-17 (Pubitemid 26132262)
12. Sheng JG, Mrak RE, Griffin WS: Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. Acta Neuropathol 1997, 94:1-5
13. Perlmutter LS, Barron E, Chui HC: Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease. Neurosci Lett 1990, 119:32-36 (Pubitemid 20349720)
14. Trojanowski JQ, Shin RW, Schmidt ML, Lee VM: Relationship between plaques, tangles, and dystrophic processes in Alzheimer's disease. Neurobiol Aging 1995, 16:335-345
15. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II: Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41:479-486
16. Mena R, Wischik CM, Novak M, Milstein C, Cuello C: A progressive deposition of paired helical filaments (PHF) in the brain characterizes the evolution of dementia in Alzheimer's disease. J Neuropathol Exp Neurol 1991, 50:474-490
17. Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM, McDonald B, Litchfield S, Smith A, Barnetson L, Smith AD: Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. Dementia 1995, 6:21-31
18. Yankner BA: Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 1996, 16:921-932 (Pubitemid 26171198)
19. Emre M, Geula C, Ransil BJ, Mesulam MM: The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected betaamyloid in the rat brain. Neurobiol Aging 1992, 13:553-559
20. Yankner BA, Duffy LK, Kirschner DA: Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 1990, 250:279-282 (Pubitemid 120031753)
21. Geula C, Wu C-K, Saroff D, Lorenzo A, Yuan M, Yankner BA: Aging renders the brain vulnerable to amyloid β-protein neurotoxicity. Nat Med 1998, 4:827-831 (Pubitemid 28331025)
22. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ: Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002, 416:535-539 (Pubitemid 34288854)
23. Selkoe DJ: Alzheimer's disease is a synaptic failure. Science 2002, 298:789-791
24. Pigino G, Morfini G, Atagi Y, Deshpande A, Yu C, Jungbauer L, LaDu M, Busciglio J, Brady S: Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta. Proc Natl Acad Sci USA: 2009, 106:5907-5912
25. Chromy BA, Nowak RJ, Lambert MP, Viola KL, Chang L, Velasco PT, Jones BW, Fernandez SJ, Lacor PN, Horowitz P, Finch CE, Krafft GA, Klein WL: Self-assembly of Abeta(1-42) into globular neurotoxins. Biochem 2003, 42:12749-12760
26. Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG: Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 2005, 280:17294-17300 (Pubitemid 41389198)
27. Kayed R, Sokolov Y, Edmonds B, McIntire TM, Milton SC, Hall JE, Glabe CG: Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem 2004, 279:46363-46366 (Pubitemid 39518276)
28. Lambert MP, Viola KL, Chromy BA, Chang L, Morgan TE, Yu J, Venton DL, Krafft GA, Finch CE, Klein WL: Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies. J Neurochem 2001, 79:595-605 (Pubitemid 33029933)
29. Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yamaguchi H, Beal MF, Xu H, Greengard P, Gouras GK: Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 2002, 161:1869-1879
30. Takahashi RH, Almeida CG, Kearney PF, Yu F, Lin MT, Milner TA, Gouras GK: Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J Neurosci 2004, 24:3592-3599 (Pubitemid 38481116)
31. Salehi A, Bakker JM, Mulder M, Swaab DF: Limited effect of neuritic plaques on neuronal density in the hippocampal CA1 area of Alzheimer patients. Alzh Dis Assoc Dis 1998, 12:77-82 (Pubitemid 29108213)
32. Knowles RB, Gomez-Isla T, Hyman BT: Abeta associated neuropil changes: correlation with neuronal loss and dementia. J Neuropathol Exp Neurol 1998, 57:1122-1130 (Pubitemid 28562740)
33. Sheng JG, Zhou XQ, Mrak RE, Griffin WS: Progressive neuronal injury associated with amyloid plaque formation in Alzheimer disease. J Neuropathol Exp Neurol 1998, 57:714-717 (Pubitemid 28335060)
34. Benes FM, Farol PA, Majocha RE, Marotta CA, Bird ED: Evidence for axonal loss in regions occupied by senile plaques in Alzheimer cortex. Neurosci 1991, 42:651-660
35. Urbanc B, Cruz L, Le R, Sanders J, Ashe KH, Duff K, Stanley HE, Irizarry MC, Hyman BT: Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease. Proc Natl Acad Sci USA: 2002, 99:13990-13995
36. Geula C, Nagykery N, Nicholas A, Wu CK: Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease. J Neuropathol Exp Neurol 2008, 67:309-318
37. Geula C, Mesulam M-M, Saroff DM, Wu C-K: Relationship between plaques, tangles, and loss of cortical cholinergic fibers in Alzheimer's disease. J Neuropathol Exp Neurol 1998, 57:63-75
38. Geula C, Mesulam M-M: Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease. Cerebral Cort 1996, 6:165-177
39. Mesulam M-M, Geula C: Overlap between acetylcholinesterase-rich and choline acetyltransferase-positive (cholinergic) axons in human cerebral cortex. Brain Res 1992, 577:112-120
40. Hanker JS, Thornburg LP, Yates PE, Moore HG: The demonstration of cholinesterases by the formation of osmium blacks at sites of Hatchett's brown. Histochemie 1973, 37:223-242
41. Tago H, Kimura H, Maeda T: Visualization of detailed acetylcholinesterase fiber and neuron staining in rat brain by a sensitive histochemical staining. J Histochem Cytochem 1986, 34:1431-1438
42. Geula C, Mesulam M-M: Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease. Brain Res 1989, 498:185-189
43. Levey AI, Bolam JP, Rye DB, Hallanger AE, Demuth RM, Mesulam M-M, Wainer BH: A light and electron microscopic procedure for sequential double antigen localization using diaminobenzidine and benzidine dihydrochloride. J Histochem Cytochem 1986, 34:1449-1457
44. Sani S, Klink A, Traul D, Niaraki N, Wu C-K, Geula C: Distribution, progression and chemical composition of cortical amyloid-beta deposits in aged rhesus monkeys: similarities to the human. Acta Neuropathol 2003, 105:145-156
45. Meyer-Luehmann M, Spires-Jones TL, Prada C, Garcia-Alloza M, de Calignon A, Rozkalne A, Koenigsknecht-Talboo J, Holtzman DM, Bacskai BJ, Hyman BT: Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 2008, 451:720-724
46. Lauckner J, Frey P, Geula C: Comparative distribution of tau phosphorylated at Ser262 in pre-tangles and tangles. Neurobiol Aging 2003, 24:767-776
47. Leung E, Guo L, Bu J, Maloof M, El Khoury J, Geula C: Microglia activation mediates fibrillar amyloid-β toxicity in the aged primate cortex. Neurobiol Aging 2009, doi: 10.1016.j.neurobiolaging.2009.02.025
48. Cheng IH, Scearce-Levie K, Legleiter J, Palop JJ, Gerstein H, Bien-Ly N, Puolivali J, Lesne S, Ashe KH, Muchowski PJ, Mucke L: Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J Biol Chem 2007, 282:23818-23828
49. Busciglio J, Lorenzo A, Yeh J, Yankner BA: beta-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 1995, 14:879-888
50. Mattson MP, Tomaselli KJ, Rydel RE: Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF. Brain Res 1993, 621:35-49
51. Kowall NW, Beal MF, Busciglio J, Duffy LK, Yankner BA: An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. Proc Nat Acad Sci U S A 1991, 88:7247-7251 (Pubitemid 21915127)
52. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL: Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 1998, 95:6448-6453
53. Leissring MA, Farris W, Chang AY, Walsh DM, Wu X, Sun X, Frosch MP, Selkoe DJ: Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 2003, 40:1087-1093 (Pubitemid 38032786)
54. Takeuchi A, Irizarry MC, Duff K, Saido TC, Hsiao AK, Hasegawa M, Mann DM, Hyman BT, Iwatsubo T: Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. Am J Pathol 2000, 157:331-339
55. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, Mcconlogue L: High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 2000, 20:4050-4058
56. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R: Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci 2006, 26:10129-10140
57. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM: Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 2005, 45:675-688
58. Nichols MR, Moss MA, Reed DK, Cratic-McDaniel S, Hoh JH, Rosenberry TL: Amyloid-beta protofibrils differ from amyloid-beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology. J Biol Chem 2005, 280:2471-2480
59. Narayanan S, Reif B: Characterization of chemical exchange between soluble and aggregated states of beta-amyloid by solution-state NMR upon variation of salt conditions. Biochem 2005, 44:1444-1452
60. Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004, 256:183-194
61. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999, 56:303-308